Integrative Hair Restoration: Evidence-Based Strategies I Use To Reboot Follicle Health and Hair Growth
Abstract
In this educational post, I walk you through how hair follicles function, why hair loss happens, and what modern, evidence-based interventions can help restore growth. I explain the physiology of hair cycling (anagen, catagen, telogen), the role of the dermal papilla and stem cell niches, and how cellular energy, hormones, and microvascular health drive follicle outcomes. I present current research on topical and oral agents (minoxidil, finasteride, dutasteride), low-level light therapy, platelet-rich plasma (PRP), microneedling with exosomes, and copper-peptide complexes (GHK-Cu and AHK-Cu), including where the evidence is strongest and what trade-offs patients must consider. I also outline future directions in regenerative care, including MUSE cells and stem-cell–derived biologics. I detail how our multidisciplinary team at Injury Medical Clinic PA in El Paso, Texas, integrates chiropractic care, internal medicine oversight, functional medicine, rehabilitation, and personal injury services. Under the medical direction of Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), we coordinate safe, personalized, and outcome-focused protocols. I share practical insights from my clinical experience as Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, and highlight how integrative chiropractic methods contribute meaningfully to hair restoration by optimizing systemic inflammation, autonomic balance, microcirculation, and mitochondrial function.
Meet Our Multidisciplinary Hair Restoration Team in El Paso, Texas
I practice at Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, where a physician-chiropractor collaboration is central to our model. Our Medical Director and Collaborative Physician is Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933. With over 40 years of experience as an internist, Dr. Cardenas oversees medical protocols, ensures safety, and collaborates with me on integrated care plans.
Dr. Maria Cardenas, MD: Medical Director, Internal Medicine oversight, medication management, lab evaluation, differential diagnosis, risk mitigation.
Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST: Chiropractic and functional medicine integration, autonomic regulation, vascular and lymphatic optimization, musculoskeletal balance, nutrition, and regenerative adjuncts.
Rehabilitation and Injury Care: Therapeutic exercise, ergonomic correction, postural retraining, and laser/light modalities.
Functional Medicine: Metabolic, hormonal, micronutrient, and mitochondrial assessments to address root causes affecting follicle health.
This multidisciplinary setup is common in integrative and injury care clinics: an MD provides medical direction, while the chiropractor and allied professionals deliver coordinated, hands-on, and lifestyle-based interventions. Together, we standardize protocols, monitor safety, and track outcomes with validated measures.
Hair Follicle Biology: Why The Dermal Papilla Is The “Brain” Of The Follicle
I like to start at first principles: the hair follicle unit in the dermis comprises the dermal papilla, matrix keratinocytes, melanocytes, and stem cells in specialized niches. These cells synchronize signals that regulate the hair cycle phases: anagen (growth), catagen (regression), and telogen (resting), with shedding following telogen. At any given time, roughly 80–90% of healthy scalp follicles should be in anagen. When that balance shifts—more follicles entering telogen or staying arrested—the visible density thins.
The dermal papilla acts as a command center, integrating angiogenic, neuroendocrine, and paracrine signals to drive matrix keratinocyte proliferation.
The bulge stem cell niche holds epithelial stem cells that fuel regeneration during anagen re-entry.
Mitochondria within follicular cells supply ATP for DNA synthesis and protein production; energy deficits stall growth.
Microvascular delivery provides oxygen, iron, and amino acids crucial for keratin assembly and melanogenesis.
Hormonal regulation—especially androgens via dihydrotestosterone (DHT)—modulates follicle size and cycling.
Physiologically, successful hair growth requires coordinated inputs: adequate DNA replication, protein synthesis, robust cell proliferation, mitochondrial energy, and balanced hormonal signaling. Disruption in any component can tip follicles out of anagen.
References:
Hair follicle stem cells and follicular cycling: integrative signaling (Hsu et al., 2014/2015)
Dermal papilla signaling and hair growth (Greco et al., 2009)
Mitochondrial bioenergetics in hair follicle function (Kloepper et al., 2015)
In-text citations: Hsu et al., 2014/2015; Greco et al., 2009; Kloepper et al., 2015.
Prevalence and Patterns: Androgenetic Alopecia, Telogen Effluvium, Autoimmune and Scarring Forms
Globally, about a billion people experience some form of hair loss; in the United States, ~80 million are affected. Androgenetic alopecia (AGA) is the most common, with men often noticing recession and vertex thinning in their 20s–30s, while women experience diffuse thinning, especially post-menopause. Alopecia areata involves an autoimmune attack on the follicle, presenting with patchy loss. Telogen effluvium accelerates shedding due to systemic stressors—illness, nutritional deficits, pregnancy, and medications. Traction and scarring alopecias involve mechanical and inflammatory damage, leading to permanent loss if unchecked.
Men: Up to ~80% lifetime risk of AGA.
Women: By ages 70–80, up to ~50% report significant thinning.
References:
Epidemiology of androgenetic alopecia (Price, 1999)
Female pattern hair loss (Blumeyer et al., 2011; Olsen, 2001 review)
Telogen effluvium mechanisms (Headington, 1993; updated reviews)
In-text citations: Price, 1999; Olsen, 2001; Headington, 1993.
Hormones and Mitochondria: Why DHT and Energy Metabolism Matter
In AGA, DHT binds androgen receptors in susceptible follicles, shrinking the dermal papilla and miniaturizing hair shafts. This androgen-driven remodeling shortens anagen and prolongs telogen, progressively reducing density. Meanwhile, mitochondrial efficiency influences keratinocyte proliferation and resilience against oxidative stress. Low ATP or high reactive oxygen species (ROS) impairs DNA replication, triggers apoptosis, and weakens the hair shaft.
5-alpha-reductase in follicular tissue converts testosterone to DHT; Type II isoform is key in scalp AGA.
Oxidative stress and inflammation around the follicle can lock follicles in telogen and scar microenvironments if chronic.
Nutrient sufficiency (iron, zinc, biotin as B7, amino acids) supports keratin production and mitochondrial enzymes.
References:
Androgens and hair follicle biology (Randall, 2011)
Oxidative stress in hair aging and loss (Trüeb, 2009)
In-text citations: Randall, 2011; Trüeb, 2009.
Conventional Pharmacologics: Minoxidil, Finasteride, Dutasteride — Benefits and Trade-Offs
I counsel patients carefully about the realistic benefits and trade-offs of medications.
Minoxidil: A topical vasodilator that increases microcirculation and prolongs anagen. It can thicken miniaturized hairs, but gains often regress when treatment stops. Oral low-dose minoxidil is increasingly studied for hair disorders.
Why we use it: To deliver more blood flow and extend growth cycles, especially in early AGA or telogen effluvium.
Key caveat: It tends to be a long-term commitment; discontinuation often reverses improvements.
Finasteride (Propecia): A Type II 5-alpha-reductase inhibitor reducing DHT, slowing progression and improving density in men.
Why we use it: To reduce androgenic miniaturization in susceptible follicles.
Caveats: Potential sexual side effects; mood changes have been reported. We weigh risks, monitor closely, and individualize dosing.
Dutasteride (Avodart): Inhibits both Type I and II 5-alpha-reductase, suppressing DHT more profoundly (~90% vs. ~70% for finasteride).
Why we use it: For cases needing stronger DHT suppression.
Caveats: Longer half-life (4–5 weeks), potentially more persistent side effects; controversy about neuropsychiatric risks has been debated in literature and regulatory discussions.
References:
Minoxidil mechanisms and outcomes (Messenger & Rundegren, 1999)
Finasteride in AGA (Kaufman et al., 1998)
Dutasteride efficacy and safety (Olsen et al., 2006; comparative reviews)
In-text citations: Messenger & Rundegren, 1999; Kaufman et al., 1998; Olsen et al., 2006.
My rule: medications can help, but they are not the only path. We emphasize multimodal protocols to reduce reliance on lifelong pharmacology when possible, especially for patients concerned about sexual side effects or systemic exposure.
Platelet-Rich Plasma (PRP): Why I Consider It a Foundation in Regenerative Hair Care
I routinely recommend PRP for hair restoration due to its favorable risk-benefit profile and robust evidence base. PRP contains concentrated platelets that release growth factors such as PDGF, VEGF, FGF, and IGF-1 upon activation.
Mechanisms:
Angiogenesis: VEGF promotes new microvessels, enhancing oxygen and nutrient delivery to the dermal papilla.
Matrix stimulation: PDGF and FGF support fibroblast and keratinocyte activity to rebuild the papilla microenvironment.
Anti-inflammation: Bioactive peptides modulate local immune responses, reducing perifollicular inflammation.
Anagen re-entry: Growth factors help reset cycling, increasing hair density and shaft thickness.
Why we use PRP:
It is autologous, well-tolerated, and synergizes with other treatments like microneedling and exosomes.
It can be structured as a series (e.g., monthly for 3 months, then maintenance every 6–12 months), offering durable benefits without sexual side effects.
References:
PRP in AGA: randomized controlled data (Gentile et al., 2015)
PRP meta-analyses (Gupta et al., 2019)
In-text citations: Gentile et al., 2015; Gupta et al., 2019.
Microneedling and Exosomes: Delivering Signals That Reprogram Follicle Microenvironments
Microneedling with a derma roller creates controlled microchannels through the stratum corneum into the upper dermis. This microtrauma recruits immune and progenitor cells, boosts collagen/elastin remodeling, and improves transdermal delivery of topicals. I often pair microneedling with exosomes—cell-derived vesicles enriched with regulatory RNAs, VEGF, IGF-1, FGF, and PDGF—to modulate the papilla milieu.
Why microneedling: It enhances local perfusion, stimulates endogenous repair cascades, and facilitates absorption of bioactives.
Why exosomes: They carry concentrated signaling molecules that reduce inflammation and promote angiogenesis, pushing follicles toward anagen. Studies show response rates often in the 70–80% range for AGA when protocols are consistent.
Technique pearls:
Apply exosome formulation, then perform microneedling so the bioactives are driven into microchannels; or needle first and apply after—both approaches are used. I prefer applying exosomes first for uniform distribution.
Typical needle depth: superficial, just beyond the stratum corneum (1–2 mm), minimizing downtime.
References:
Microneedling for hair growth (Dhurat et al., 2013)
Exosomes in skin and hair regeneration (Zhang et al., 2019; emerging clinical reports)
In-text citations: Dhurat et al., 2013; Zhang et al., 2019.
Copper Peptides GHK-Cu and AHK-Cu: Angiogenesis, Wnt/β-Catenin, and Papilla Remodeling
The tripeptide GHK-Cu is a naturally occurring copper-binding peptide involved in tissue repair and angiogenesis. It has been shown to activate Wnt/β-catenin pathways implicated in hair follicle stem cell activation. An analog, AHK-Cu, demonstrates stronger activity in some experimental contexts. Topical formulations combining GHK-Cu and AHK-Cu aim to energize the dermal papilla and support follicle growth with minimal systemic side effects.
Mechanisms:
Upregulates VEGF to enhance microvascular supply.
Supports fibroblast biosynthesis, helping rebuild the papilla and extracellular matrix.
Modulates Wnt signaling, encouraging stem cell-driven entry into anagen.
Why I use it:
As a low-risk adjunct that can be applied long term without sexual side effects.
Particularly useful for patients reluctant to use systemic DHT blockers.
References:
GHK-Cu biology and skin repair (Pickart & Margolina, 2014)
Wnt/β-catenin in hair follicle activation (Lien et al., 2014)
In-text citations: Pickart & Margolina, 2014; Lien et al., 2014.
Low-Level Light Therapy (Red/NIR): Photobiomodulation To Boost Mitochondria and Microcirculation
Low-level light therapy (LLLT) in the red and near-infrared spectrum can stimulate cytochrome c oxidase in mitochondria, increasing ATP production, nitric oxide release, and microcirculatory dilation—effects that support anagen. It is non-invasive and can be home-based with appropriate devices.
Why we recommend it:
Synergy with PRP, exosomes, and peptides.
Improves scalp perfusion, reduces inflammation, and supports energy metabolism.
References:
LLLT for hair growth: systematic review (Avci et al., 2014)
Photobiomodulation mechanisms (Hamblin, 2016)
In-text citations: Avci et al., 2014; Hamblin, 2016.
Nutritional and Functional Medicine Supports: Iron, Zinc, Biotin, Antioxidants, and Mitochondrial Cofactors
In our clinic, we evaluate iron status (ferritin), zinc, vitamin D, biotin (B7), amino acid sufficiency, and thyroid function. Deficits create bottlenecks in keratin synthesis and mitochondrial enzyme systems. We also use antioxidants to reduce oxidative stress around follicles.
Biotin: Supports keratin infrastructure; deficiency can exacerbate thinning. Some PRP kits include biotin to enrich local delivery.
Nicotinamide: Supports the barrier and is a NAD+ precursor that impacts cellular energy.
Caffeine: Topical formulations may improve microcirculation and counteract DHT locally.
CoQ10, alpha-lipoic acid, carnitine: Target mitochondrial efficiency and ROS balance.
Why we use these:
To correct systemic constraints that limit follicular regeneration.
To complement local therapies so gains are sustainable.
References:
Micronutrients and hair loss (Almohanna et al., 2019)
Ferritin and hair shedding (Trost et al., 2006)
In-text citations: Almohanna et al., 2019; Trost et al., 2006.
How Integrative Chiropractic Care Fits Into Hair Restoration
Chiropractic is often overlooked in hair health, yet systemic physiology links spine, autonomic tone, and microvascular performance to follicle function. My approach integrates:
Autonomic regulation: Gentle spinal adjustments and vagal-supportive techniques can shift sympathetic overdrive, reducing stress-mediated telogen effluvium. Lowering cortisol and catecholamines helps normalize microvascular tone and immune balance.
Posture, mobility, and circulation: Cervical and cranial mobility can influence regional perfusion and lymphatic drainage. Improved neck and scalp fascial glide supports nutrient delivery and waste clearance.
Inflammation reduction: Musculoskeletal dysfunctions can sustain systemic inflammation. Correcting joint mechanics and soft tissue dysfunction reduces cytokines that otherwise impair follicles.
Exercise prescription: Movement plans enhance global and scalp microcirculation and mitochondrial biogenesis.
Breathwork and HRV coaching: We use breathing drills and biofeedback to improve heart rate variability, attenuating stress responses connected to telogen entry.
These methods complement medical interventions, making outcomes more robust and resilient. My clinical observations across thousands of cases—documented throughout my platforms—show that patients combining chiropractic, functional medicine, and regenerative therapies often sustain gains longer, with fewer setbacks:
Clinical insights:
https://dralexjimenez.com/
https://www.elpasochiropractorblog.com/
https://www.linkedin.com/in/dralexjimenez/
References:
Autonomic balance, stress, and hair cycling (Paus et al., 2013)
Fascial and lymphatic dynamics in scalp health (Schleip et al., 2017)
In-text citations: Paus et al., 2013; Schleip et al., 2017.
Practical Protocols We Use: Layering Modalities For Sustained Results
I design individualized plans, but common frameworks look like this:
Baseline assessment
Medical history, medications, endocrine status.
Labs: ferritin, TSH/free T4/T3, vitamin D, zinc, CRP, fasting insulin/HbA1c as needed.
Trichoscopy and standardized photos for density and caliber tracking.
First-line non-pharmacologic
PRP series: 3 sessions at monthly intervals, then maintenance at 6–12 months.
Microneedling + exosomes: Monthly for 3–4 months, then quarterly.
Copper peptides (GHK-Cu/AHK-Cu): Daily topical application; derma roller every 2–3 weeks to enhance penetration.
LLLT: 3–4 times per week, 10–20 minutes, validated device.
Functional supports
Correct iron, zinc, vitamin D, biotin, optimize protein intake.
Add CoQ10 and nicotinamide where mitochondrial support is indicated.
Anti-inflammatory diet rich in polyphenols; limit smoking and alcohol.
Chiropractic integration
Cervical/thoracic adjustments, cranial fascial mobilization.
Breathing and HRV training; postural and sleep optimization.
Stress management: mindfulness, graded exercise.
Pharmacologic options (as needed, with Dr. Cardenas’ oversight)
Topical minoxidil or low-dose oral minoxidil.
Finasteride or dutasteride for appropriate candidates, with informed consent and side-effect monitoring.
Topical antiandrogens where systemic exposure is a concern.
Follow-up
Outcomes tracked at 12–16 weeks, 6 months, and annually.
Adjust protocol intensity based on response and preferences.
Rationale:
We aim to reestablish anagen dominance by improving microvascular flow, lowering inflammation, and energizing cellular machinery.
We prefer regenerative signals (PRP, exosomes, peptides) to remodel the dermal papilla and extracellular matrix, while using medications judiciously to control DHT-driven miniaturization.
Chiropractic and lifestyle pivots reduce triggers for telogen effluvium and help sustain microvascular health.
References:
Integrated PRP protocols in AGA (Singh et al., 2020)
Lifestyle and endocrine modulation in hair disorders (Paus & Arck, 2009; updated reviews)
In-text citations: Singh et al., 2020; Paus & Arck, 2009.
Hair Transplantation: Roles and Risks
Hair transplantation can help in advanced AGA, but it is not a panacea. We discuss cost, donor-site limitations, potential scarring, and the need to maintain non-transplanted areas with medical/regenerative therapy to avoid a “halo” of thinning around transplanted islands.
Why we sometimes defer:
If inflammation and microvascular deficits are not corrected, transplant results can be suboptimal.
Patients may benefit first from PRP/exosomes/LLLT to improve global scalp health and better predict transplant success.
References:
Hair transplantation outcomes and adjunct therapies (Jimenez & Ruifernandez, 1999; modern reviews)
In-text citations: Jimenez & Ruifernandez, 1999.
Future Directions: MUSE Cells and Stem-Cell–Derived Biologics
The field is moving toward pluripotent-like cell populations such as MUSE cells (multilineage-differentiating stress-enduring cells) that can differentiate across germ layers, including ectoderm relevant to hair follicles. While still experimental, early work suggests potential to regenerate more robust follicle architecture when combined with sophisticated scaffolds and signaling cues.
Why we’re watching this:
Potential to rebuild the dermal papilla and reconstitute stem cell niches more completely.
Could offer durable solutions for scarring alopecias where follicles are destroyed.
References:
MUSE cells characterization (Kuroda et al., 2010/2011)
Stem cells in hair follicle regeneration (Plikus et al., 2019)
In-text citations: Kuroda et al., 2011; Plikus et al., 2019.
Patient Journey: A Clear, Stepwise Path With Realistic Expectations
I want patients to feel the journey is understandable and manageable. Here’s how I frame it:
Step 1: Understand your diagnosis. Is it AGA, telogen effluvium, alopecia areata, traction, or scarring?
Step 2: Optimize biology. Correct nutrients, reduce inflammation, improve autonomic balance and microcirculation.
Step 3: Activate growth. Use PRP, microneedling with exosomes, copper peptides, and LLLT to restore anagen.
Step 4: Control drivers. Consider targeted pharmacology to modulate DHT and sustain gains if appropriate.
Step 5: Maintain and adapt. Periodic boosters (PRP/exosomes/peptides), continued lifestyle, and chiropractic support; reassess at specific dates.
This structure helps avoid the common “start-and-stop” cycle where discontinuation rapidly reverses progress. Instead, we maintain momentum with low-risk regenerative boosters—often every 6–12 months—rather than relying solely on daily pharmaceuticals.
Cost, Safety, and Personalization: Choosing The Right Mix
I guide patients through cost-benefit considerations:
PRP: High evidence, autologous safety, moderate cost; scalable frequency.
Exosomes: Strong signals, growing evidence, costs vary; best delivered with microneedling.
Peptides: Low side-effect profile, daily adherence needed; cost-effective long-term.
LLLT: Upfront device cost; excellent at-home adjunct.
Pharmacology: Effective for DHT suppression; weigh sexual and mood side effects, especially with long half-life agents.
With Dr. Cardenas’ medical oversight, we tailor to the patient’s medical history, budget, and goals. Our integrated team ensures informed consent, monitors outcomes, and pivots treatments based on objective measures.
Clinical Observations and Real-World Outcomes
In the clinic, I consistently observe that:
Patients combining PRP + microneedling/exosomes + copper peptides + LLLT see measurable increases in hair density and shaft caliber within 12–16 weeks, with further gains at 6 months.
Those who add chiropractic autonomic regulation and stress reduction have fewer shedding flares and maintain anagen longer.
Nutrient corrections—especially ferritin normalization—reduce telogen shedding episodes.
You can explore more of my clinical commentaries and case discussions:
https://dralexjimenez.com/
https://www.elpasochiropractorblog.com/
https://www.linkedin.com/in/dralexjimenez/
Conclusion: Build Anagen, Support the Papilla, Personalize the Plan
Hair restoration succeeds when we invest in the dermal papilla, nourish stem cell niches, and align systemic physiology—hormones, mitochondria, microcirculation, and autonomic tone. Our multidisciplinary model with Dr. Maria Guadalupe Cardenas, MD, ensures safe, medically directed care, while integrative chiropractic and functional medicine strategies enhance resilience and outcomes. By layering regenerative signals (PRP, exosomes, peptides), supportive light therapy, strategic pharmacology, and lifestyle foundations, we help patients sustain growth without accepting unnecessary trade-offs.
If you are experiencing hair thinning or loss, we can chart a clear, evidence-based path forward—mapping your biology, activating growth, and maintaining gains thoughtfully over time.
References
Hair follicle stem cells and follicular cycling: integrative signaling (Hsu, Y.-C., Li, L., & Fuchs, E., 2014/2015). Nature Reviews Molecular Cell Biology.
Dermal papilla signaling and hair growth (Greco, V. et al., 2009). Nature.
Mitochondrial bioenergetics in hair follicle function (Kloepper, J. E. et al., 2015). Journal of Investigative Dermatology.
Epidemiology of androgenetic alopecia (Price, V. H., 1999). Archives of Dermatology.
Female pattern hair loss (Olsen, E. A., 2001; consensus updates). New England Journal of Medicine.
Telogen effluvium mechanisms (Headington, J. T., 1993). Journal of Investigative Dermatology.
Androgens and hair follicle biology (Randall, V. A., 2011). Nature Reviews Endocrinology.
Oxidative stress in hair aging and loss (Trüeb, R. M., 2009). Journal of Investigative Dermatology Symposium Proceedings.
Minoxidil mechanisms and outcomes (Messenger, A. G., & Rundegren, J., 1999). Dermatologic Therapy.
Finasteride in AGA (Kaufman, K. D., et al., 1998). New England Journal of Medicine.
Dutasteride efficacy and safety (Olsen, E. A., et al., 2006). British Journal of Dermatology.
PRP in AGA: randomized controlled data (Gentile, P., et al., 2015). Archives of Dermatological Research.
PRP meta-analyses (Gupta, A. K., et al., 2019). Journal of the American Academy of Dermatology.
Microneedling for hair growth (Dhurat, R., et al., 2013). Dermatologic Therapy.
Exosomes in skin and hair regeneration (Zhang, B., et al., 2019). Journal of Investigative Dermatology.
GHK-Cu biology and skin repair (Pickart, L., & Margolina, A., 2014). International Journal of Molecular Sciences.
Wnt/β-catenin in hair follicle activation (Lien, W.-H., et al., 2014). Cell Reports.
LLLT for hair growth: systematic review (Avci, P., et al., 2014). Dermatologic Therapy.
Photobiomodulation mechanisms (Hamblin, M. R., 2016). Photobiomodulation, Photomedicine, and Laser Surgery.
Micronutrients and hair loss (Almohanna, H. M., et al., 2019). Archives of Dermatological Research.
Ferritin and hair shedding (Trost, L. B., et al., 2006). Journal of Investigative Dermatology.
Autonomic balance, stress, and hair cycling (Paus, R. et al., 2013). Journal of Investigative Dermatology.
Fascial and lymphatic dynamics in scalp health (Schleip, R., et al., 2017). Journal of Bodywork and Movement Therapies.
Integrated PRP protocols in AGA (Singh, S., et al., 2020). Dermatologic Therapy.
Lifestyle and endocrine modulation in hair disorders (Paus, R., & Arck, P. C., 2009). Experimental Dermatology.
Hair transplantation outcomes and adjunct therapies (Jimenez, F., & Ruifernandez, J., 1999). British Journal of Dermatology.
MUSE cells characterization (Kuroda, Y., et al., 2011). Nature.
Stem cells in hair follicle regeneration (Plikus, M. V., et al., 2019). Stem Cell Reports.
The information herein is not intended to replace a one-on-one relationship with a qualified healthcare professional or licensed physician and is not medical advice. We encourage you to make healthcare decisions based on your research and partnership with a qualified healthcare professional. Our information scope is limited to chiropractic, musculoskeletal, and physical medicine, as well as wellness, sensitive health issues, and functional medicine articles, topics, and discussions. We provide and facilitate clinical collaboration with specialists across disciplines. Each specialist is governed by their professional scope of practice and the jurisdiction in which they are licensed. We utilize functional health and wellness protocols to treat and support care for musculoskeletal injuries or disorders. Our videos, posts, topics, subjects, and insights cover clinical matters and issues that directly or indirectly support our clinical scope of practice. Our office has made a reasonable effort to provide supportive citations and identify relevant research studies for our posts. We provide copies of supporting research studies upon request to regulatory boards and the public.
We are here to help you and your family.
Blessings
Dr. Alex Jimenez, DC, MSACP, APRN, FNP-BC*, CCST, IFMCP, CFMP, ATN
email: coach@elpasofunctionalmedicine.com
Multidisciplinary Licensing & Board Certifications:
Licensed as a Doctor of Chiropractic (DC) in Texas & New Mexico*
Texas DC License #: TX5807, Verified: TX5807
New Mexico DC License #: NM-DC2182, Verified: NM-DC2182
Multi-State Advanced Practice Registered Nurse (APRN*) in Texas & Multi-States
Multi-State Compact APRN License by Endorsement (42 States)
Texas APRN License #: 1191402, Verified: 1191402 *
Florida APRN License #: 11043890, Verified: APRN11043890 *
New York APRN License #: N25929, Verified: APRN-N25929*
License Verification Link: Nursys License Verifier
* Prescriptive Authority Authorized
ANCC FNP-BC: Board Certified Nurse Practitioner*
Compact Status: Multi-State License: Authorized to Practice in 40 States*
Graduate with Honors: ICHS: MSN-FNP (Family Nurse Practitioner Program)
Degree Granted. Master's in Family Practice MSN Diploma (Cum Laude)
Dr. Alex Jimenez, DC, APRN, FNP-BC*, CFMP, IFMCP, ATN, CCST
My Digital Business Card
Dr. Maria Cardenas, MD
(Board Certified in Internal Medicine)
Medical Director & Collaborative Physician
NPI # 1164426749
MD License #: J2933
